topic:"Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs" found 9 records - Canadian Medical Association

It appears no script is enabled within your browser. Please enable JavaScript to use this site.

CMA PolicyBase

Policies that advocate for the medical profession and Canadians

Revise Search

9 records – page 1 of 1.

Catastrophic prescription drug program

https://policybase.cma.ca/en/permalink/policy8841

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-11; The Canadian Medical Association urges the Canadian Institute for Health Information and Statistics Canada to conduct a detailed study of the socio-economic profile of Canadians who have out-of-pocket prescription drug expenses to assess barriers to access and to design strategies that could be built into a catastrophic prescription drug program.

Policy Type: Policy resolution

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-11; The Canadian Medical Association urges the Canadian Institute for Health Information and Statistics Canada to conduct a detailed study of the socio-economic profile of Canadians who have out-of-pocket prescription drug expenses to assess barriers to access and to design strategies that could be built into a catastrophic prescription drug program.

Chalk River National Research Universal reactor

https://policybase.cma.ca/en/permalink/policy9919

Last Reviewed: 2017-03-04

Date: 2010-08-25

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC10-102; The Canadian Medical Association urges the federal government to make a public commitment to keep the Chalk River National Research Universal reactor operational for as long as necessary beyond the announced date of 2016 and until secure alternative supplies of isotopes or alternative radiopharmaceuticals are proven and available.

Policy Type: Policy resolution

Last Reviewed: 2017-03-04

Date: 2010-08-25

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC10-102; The Canadian Medical Association urges the federal government to make a public commitment to keep the Chalk River National Research Universal reactor operational for as long as necessary beyond the announced date of 2016 and until secure alternative supplies of isotopes or alternative radiopharmaceuticals are proven and available.

Counterfeit Drugs

https://policybase.cma.ca/en/permalink/policy9068

Last Reviewed: 2020-02-29

Date: 2007-12-01

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs; Health systems, system funding and performance

Resolution: BD08-03-31; The Canadian Medical Association calls on the Government of Canada to: - implement an anti-counterfeit drugs strategy which could include track-and-trace technology, severe penalties for infractions, and an alert network to encourage reporting by health professionals and patients; and - work with other countries and international organizations on a global effort to stop drug counterfeiting.

Policy Type: Policy resolution

Last Reviewed: 2020-02-29

Date: 2007-12-01

Topics: Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs; Health systems, system funding and performance

Resolution: BD08-03-31; The Canadian Medical Association calls on the Government of Canada to: - implement an anti-counterfeit drugs strategy which could include track-and-trace technology, severe penalties for infractions, and an alert network to encourage reporting by health professionals and patients; and - work with other countries and international organizations on a global effort to stop drug counterfeiting.

Delegated professional prescribing

https://policybase.cma.ca/en/permalink/policy8865

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-35; The Canadian Medical Association affirms that within a multidisciplinary practice delegated professional prescribing is only acceptable when led by a physician clinical leader with ultimate responsibility for patient care.

Policy Type: Policy resolution

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-35; The Canadian Medical Association affirms that within a multidisciplinary practice delegated professional prescribing is only acceptable when led by a physician clinical leader with ultimate responsibility for patient care.

E-prescribing

https://policybase.cma.ca/en/permalink/policy9538

Last Reviewed: 2016-05-20

Date: 2009-08-19

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC09-42; The Canadian Medical Association and provincial/territorial medical associations will work with governments to accelerate the introduction of e-prescribing in Canada to make it the main method of prescribing by 2012.

Policy Type: Policy resolution

Last Reviewed: 2016-05-20

Date: 2009-08-19

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC09-42; The Canadian Medical Association and provincial/territorial medical associations will work with governments to accelerate the introduction of e-prescribing in Canada to make it the main method of prescribing by 2012.

Expanding the public plan coverage of health services

https://policybase.cma.ca/en/permalink/policy8855

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-25; The Canadian Medical Association believes that any request for expanding the public plan coverage of health services, in particular for home care services and the cost of prescription drugs, must include a comprehensive analysis of the potential sources of financing for this expansion.

Policy Type: Policy resolution

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-25; The Canadian Medical Association believes that any request for expanding the public plan coverage of health services, in particular for home care services and the cost of prescription drugs, must include a comprehensive analysis of the potential sources of financing for this expansion.

High cost of drugs

https://policybase.cma.ca/en/permalink/policy8906

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Health care and patient safety; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-92; The Canadian Medical Association urges governments to take prompt measures to address the high cost of generic and off-patent prescription drugs in Canada.

Policy Type: Policy resolution

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Health care and patient safety; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-92; The Canadian Medical Association urges governments to take prompt measures to address the high cost of generic and off-patent prescription drugs in Canada.

Inclusion of expensive drugs

https://policybase.cma.ca/en/permalink/policy8854

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-24; The Canadian Medical Association urges the federal government to assess the options for risk pooling to cover the inclusion of expensive drugs in public and private drug plan formularies.

Policy Type: Policy resolution

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-24; The Canadian Medical Association urges the federal government to assess the options for risk pooling to cover the inclusion of expensive drugs in public and private drug plan formularies.

Public prescription drug insurance plans

https://policybase.cma.ca/en/permalink/policy8852

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-22; The Canadian Medical Association calls on the federal government to provide adequate financial compensation to the provincial and territorial governments that have developed, implemented and funded their own public prescription drug insurance plans.

Policy Type: Policy resolution

Last Reviewed: 2014-03-01

Date: 2007-08-22

Topics: Health systems, system funding and performance; Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs

Resolution: GC07-22; The Canadian Medical Association calls on the federal government to provide adequate financial compensation to the provincial and territorial governments that have developed, implemented and funded their own public prescription drug insurance plans.

9 records – page 1 of 1.